PI3-kinase inhibition: a target for drug development?
- 1 September 2000
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 6 (9) , 347-358
- https://doi.org/10.1016/s1357-4310(00)01770-6
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Class II Phosphoinositide 3-Kinases Are Downstream Targets of Activated Polypeptide Growth Factor ReceptorsMolecular and Cellular Biology, 2000
- A Novel Positive Feedback Loop Mediated by the Docking Protein Gab1 and Phosphatidylinositol 3-Kinase in Epidermal Growth Factor Receptor SignalingMolecular and Cellular Biology, 2000
- Signaling by Distinct Classes of Phosphoinositide 3-KinasesExperimental Cell Research, 1999
- Structure and function of phosphoinositide 3-kinasesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1998
- The stress-activated phosphatidylinositol 3-phosphate 5-kinase Fab1p is essential for vacuole function in S. cerevisiaeCurrent Biology, 1998
- Bifurcation of Lipid and Protein Kinase Signals of PI3Kγ to the Protein Kinases PKB and MAPKScience, 1998
- Fab1p Is Essential for PtdIns(3)P 5-Kinase Activity and the Maintenance of Vacuolar Size and Membrane HomeostasisThe Journal of cell biology, 1998
- PHOSPHOINOSITIDE KINASESAnnual Review of Biochemistry, 1998
- p85α Gene Generates Three Isoforms of Regulatory Subunit for Phosphatidylinositol 3-Kinase (PI 3-Kinase), p50α, p55α, and p85α, with Different PI 3-Kinase Activity Elevating Responses to InsulinPublished by Elsevier ,1997
- A family of phosphoinositide 3-kinases in Drosophila identifies a new mediator of signal transductionCurrent Biology, 1995